USPH VS HSKA Stock Comparison

Performance

USPH
100/100

USPH returned 2.89% in the last 12 months. Based on SPY's performance of -13.44%, its performance is above average giving it a score of 100 of 100.

HSKA
100/100

HSKA returned 37.49% in the last 12 months. Based on SPY's performance of 1.96%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

USPH
61/100

7 analysts offer 12-month price targets for USPH. Together, they have an average target of 0, the most optimistic target put USPH at 0 within 12-months and the most pessimistic has USPH at 0.

HSKA
66/100

8 analysts offer 12-month price targets for HSKA. Together, they have an average target of 159.5, the most optimistic target put HSKA at 170 within 12-months and the most pessimistic has HSKA at 149. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

Sentiment

USPH
67/100

USPH had a bullish sentiment score of 66.64% across Twitter and StockTwits over the last 12 months. It had an average of 2.88 posts, 0.12 comments, and 0.00 likes per day.

HSKA
67/100

HSKA had a bullish sentiment score of 67.01% across Twitter and StockTwits over the last 12 months. It had an average of 3.93 posts, 0.07 comments, and 0.11 likes per day.

Technicals

USPH
50/100

USPH receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

HSKA
86/100

HSKA receives a 85 of 100 based on 14 indicators. 12 are bullish, 2 are bearish.

Earnings

USPH
69/100

USPH has missed earnings 2 times in the last 20 quarters.

HSKA
10/100

HSKA has missed earnings 10 times in the last 20 quarters.

Profit

USPH
61/100

Out of the last 20 quarters, USPH has had 20 profitable quarters and has increased their profits year over year on 5 of them.

HSKA
32/100

Out of the last 20 quarters, HSKA has had 5 profitable quarters and has increased their profits year over year on 5 of them.

Volatility

USPH
55/100

USPH has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.

HSKA
42/100

HSKA has had a lower than average amount of volatility over the last 12 months giving it a score of 42 of 100.

Dividend

USPH
19/100

USPH's most recent dividend was $0.82 per share, based on a share price of $87.22. It was a payout ratio of 95.21% compared to their total earnings.

HSKA

"Dividend" not found for HSKA

All score calculations are broken down here to help you make more informed investing decisions

US Physical Therapy Inc Summary

New York Stock Exchange / USPH

Healthcare

Medical - Care Facilities

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Heska Corp Summary

Nasdaq / HSKA

Healthcare

Medical Devices

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

Power up your portfolio